Speakers





Maen Obeidat
Executive Director - Therapeutics Area Head, Biomarker Development, Ophthalmology
Novartis


Matthew Wood
Luxturna Patient (UK)


































Executive Director - Therapeutics Area Head, Biomarker Development, Ophthalmology
Novartis
Luxturna Patient (UK)